Fig. 5
- ID
- ZDB-FIG-250827-38
- Publication
- Zhang et al., 2025 - IL-23 Receptor Agonism by Mulberroside C Activates the RASGRP1/RAS/ERK Pathway Contributing to Leukopenia Treatments
- Other Figures
- All Figure Page
- Back to All Figure Page
|
Flow cytometry analysis of myeloid cells in irradiated mice on day 9. Effect of Mulberroside C (MC, 2–8 mg/kg) or granulocyte colony-stimulating factor (G-CSF, 25 μg/kg) in irradiated KM mice. (A) Flow cytometry analysis of CD11b and Ly6G expression in peripheral blood, bone marrow, and spleen cells from each group. (B-D) Histograms show the percentage of CD11b+Ly6G+ cells in each group. n = 3. (E) Flow cytometry analysis of CD117 and CD34 expression in bone marrow and spleen cells from each group. (F-G) Histograms show the percentage of CD117+CD34+ cells in each group. n = 3. (H) Flow cytometry analysis of CD117 and Ly6G expression in bone marrow and spleen cells from each group. (I-J) Histograms showing the percentage of CD117+Ly6G+ cells in each group. n = 3. Data are expressed as the mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 versus the model group. |